+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

  • ID: 4763172
  • Report
  • April 2019
  • Region: United States
  • 93 pages
  • IMARC Group
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The United States Specialty Generics Market reached a value of US$ 18.4 Billion in 2018. Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs are used to treat life threatening and serious health conditions such as cancer, autoimmune diseases, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc.

Specialty generics are economical compared to specialty drugs as they don’t need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers. Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, as per the American cancer society, a total of 1,762,450 new cancer cases and 606,880 deaths from cancer are expected to occur in the United States in 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years. Looking forward, the publisher expects the market value to reach US$ 32.6 Billion by 2024, exhibiting a CAGR of around 10% during 2019-2024

Report Scope:

Historical, Current and Future Market Trends

Market Breakup by Route of Administration:


Market Breakup by Indication:

Autoimmune Diseases
Infectious Diseases

Market Breakup by Distribution channel:

Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies

Competitive Landscape:

The leading players in the US specialty generics industry have also been examined in the report.

Key Questions Answered in This Report:
  • How has the US specialty generics market performed so far and how will it perform in the coming years?
  • What is the breakup of the US specialty generics market based on the route of administration?
  • What is the breakup of the US specialty generics market based on the indication?
  • What is the breakup of the US specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the US specialty generics industry?
  • What are the key driving factors and challenges in the US specialty generics market?
  • What is the structure of the US specialty generics industry and who are the key players?
  • What is the degree of competition in the US specialty generics market?
Note: Product cover images may vary from those shown
2 of 3
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction
4.1 What are Specialty Generic Drugs?
4.2 Types of Specialty Generics

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Market Breakup by Route of Administration
6.4 Market Breakup by Indication
6.5 Market Breakup by Distribution Channel
6.6 Market Breakup by Region
6.7 Market Forecast

7 US Specialty Generics Market
7.1 Market Overview
7.2 Market Performance
7.3 Market Breakup by Route of Administration
7.4 Market Breakup by Indication
7.5 Market Breakup by Distribution Channel
7.6 Market Forecast
7.7 SWOT Analysis
7.7.1 Overview
7.7.2 Strengths
7.7.3 Weaknesses
7.7.4 Opportunities
7.7.5 Threats
7.8 Value Chain Analysis
7.9 Porters Five Forces Analysis
7.9.1 Overview
7.9.2 Bargaining Power of Buyers
7.9.3 Bargaining Power of Suppliers
7.9.4 Degree of Competition
7.9.5 Threat of New Entrants
7.9.6 Threat of Substitutes
7.10 Key Market Drivers and Success Factors

8 Market Breakup by Route of Administration
8.1 Injectables
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.1 Market Forecast

9 Market Breakup by Indication
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Autoimmune Diseases
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Infectious Diseases
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast

10 Market Breakup by Distribution Channel
10.1 Retail Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Specialty Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Hospital Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast

11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players

*List of Tables and Figures are available on enquiry
Note: Product cover images may vary from those shown
3 of 3